Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Liu-Xian Ban
Observed names:
Ban, Liuxian,
Liuxian Ban
Institutions:
Sun Yat-sen University,
Sun Yat-sen Memorial Hospital,
University of Hong Kong - Shenzhen Hospital,
University of Hong Kong
Observed institutions:
Sun Yat-sen University,
Sun Yat-sen Memorial Hospital,
University of Hong Kong - Shenzhen Hospital,
Sun Yat-sen University Cancer Center,
State Key Laboratory of Oncology in South China,
University of Hong Kong
show all 6
ORCID:
0000-0001-7180-723X
Observed ORCID:
0000-0001-7180-723X
OpenAlex ID:
A5080946232
FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
·
Cancer Research
·
130
Anti-fungal drug itraconazole exerts anti-cancer effects in oral squamous cell carcinoma via suppressing Hedgehog pathway
2020
·
Liuxian Ban
, Ting Mei
, et al.
·
Life Sciences
·
27
Multiomics identifies a cholesterol–TFEB–PLD3–TLR9 axis driving immunosuppressive tumor-associated macrophage polarization in esophageal squamous cell carcinoma
2026
·
Licheng Tan
, Hongyu Zhou
, et al.
·
Proceedings of the National Academy of Sciences
·
11
IDDF2025-ABS-0238 Histone chaperone ASF1B facilitates tumor plasticity through H3.3-dependent transcriptional regulation of SOX9 in hepatocellular carcinoma
2025
·
Xiaona Fang
, Beilei Liu
, et al.
·
Gut
·
1
Abstract 2441: Identification and characterization of the role of KRT17 in the stemness regulation of hepatocellular carcinoma
2023
·
Xiaona Fang
, Shan Liu
, et al.
·
Cancer Research
·
1
Histone Chaperone ASF1B Promotes Progenitor‐Like Cell States in Hepatocellular Carcinoma Through H3.3‐Dependent SOX9 Transcriptional Activation
2026
·
Xiaona Fang
, Beilei Liu
, et al.
·
Advanced Science
Colorectal cancer liver metastases: mechanism and therapy
2026
·
Shan Liu
, Liuxian Ban
, et al.
·
Frontiers in Immunology
PDF
Supporting data for "KIF20A Drives Stemness-Associated Tumor Plasticity Through Hippo-YAP Signaling in Hepatocellular Carcinoma"
2026
·
Ban, Liuxian
·
Hong Kong University
Abstract 4138: Integrative computational and experimental analysis identifies carcinogenic effects of 1,4-Phenylenediamine in hepatocellular carcinoma via PI3K/AKT-MAPK and JAK/STAT signaling pathway
2026
·
Liuxian Ban
, Ran Ding
, et al.
·
Cancer Research
Abstract 8: Identifying the role of KIF20A in stemness and metastasis in hepatocellular carcinoma
2025
·
Liuxian Ban
, Xiaona Fang
, et al.
·
Cancer Research
Figure S4 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S7 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S3 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Supplementary Tables from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S6 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Data from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S4 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S3 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S5 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S2 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S1 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S1 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Figure S2 from FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma
2024
·
Jiao Huang
, Wai Ying Tsang
, et al.
Abstract 2445: PPM1G enhances hepatocellular carcinoma stemness via interacting with YBX1
2023
·
Shan Liu
, Xiaona Fang
, et al.
·
Cancer Research
Show more works
View as search
Works count:
24
Citation count:
170
H-index:
3
I10-index:
3
Year
Topic
Type